
Ex Vivo
Gain detailed insights into where your radiopharmaceutical goes and how long it stays. Our ex vivo biodistribution studies provide the quantitative data essential for dosimetry and understanding tissue-level targeting.
Ex Vivo Capabilities
Comprehensive tissue analysis providing quantitative biodistribution data essential for dosimetry and regulatory submissions.
Ex Vivo Analytical Portfolio
Comprehensive analytical capabilities for tissue-level characterization, from biodistribution quantification to molecular analysis and sample preservation.
Complete Biodistribution Studies: Our "Cut and Count" studies harvest tumors and up to 20 organs per animal at multiple time points, providing %IA/g and SUV values, and time-activity curves essential for dosimetry calculations and IND submissions.
From Tissue to Data
A streamlined approach to deliver accurate results on time
Study Planning
We design tissue collection protocols with optimal time points for your compound's pharmacokinetics.
Tissue Collection
Organs and tissues are harvested following standardized protocols at predetermined time points.
Activity Measurement
Gamma counting and autoradiography quantify radioactivity distribution across all collected tissues.
Biodistribution Report
Complete analysis with %IA/g and SUV values, organ ratios, and time-activity curves for dosimetry input.
Ready to Start Your Next Radiopharmaceutical Project?
Let's discuss how our expertise can accelerate your radiopharmaceutical development program. Get in touch today for a consultation.
Explore Other Services
Comprehensive capabilities for your complete radiopharmaceutical development journey


